Comparison Between Retrolaminar Block Combined With Erector Spinae Plane Block, and Erector Spinae Plane Block Alone for Post-thoracotomy Pain
1 other identifier
interventional
32
1 country
1
Brief Summary
Post-thoracotomy pain is a challenging clinical problem that may be associated with increased morbidity and mortality. The current study tests two techniques of regional anaesthesia to control post thoracotomy pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2022
CompletedStudy Start
First participant enrolled
February 2, 2023
CompletedFirst Posted
Study publicly available on registry
March 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedAugust 30, 2023
August 1, 2023
8 months
December 16, 2022
August 29, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Total amount of morphine consumption in the first 24-hour postoperative in the two groups.
20ml for ESPB compared to 10ml ESPB added to 10ml RLB.
24 hours
Secondary Outcomes (5)
•Pain score according to VAS score
24 hours
• Heart rate
intraoperative
Incidence of complications
24 hours
.First request of analgesia postoperative
24 hours
MAP
intraoperative
Study Arms (3)
Group 1 Erector spinae plane block
EXPERIMENTALGroup 1 (ESPB (control group): (n = 15) patients will receive preoperative US-guided ESPB on the operated side by 20 ml bupivacaine 0.25%.
Group 2: Erector spinae plane block
EXPERIMENTALUS-guided ESPB with 10 ml bupivacaine 0.25% (n = 15) on the operated side.
Retro laminar block
EXPERIMENTALthe US-guided retrolaminar block 10 ml bupivacaine 0.25% group: (n = 15) on the operated side.
Interventions
Patients will be divided into 2 groups group 1 will receive US-guided ESPB and group 2 will receive US-guided ESPB + US-guided Retrolaminar plain block before induction of GA.
Patients will be divided into 2 groups group 1 will receive US-guided ESPB and group 2 will receive US-guided ESPB + US-guided Retrolaminar plain block before induction of GA.
Eligibility Criteria
You may qualify if:
- Age from 18-65 years.
- body mass index (BMI) ranged between 20 and 40 kg/m2
You may not qualify if:
- Patient refusal.
- Sensitivity or contraindication to local anesthetic drugs.
- History of psychological disorders and/or chronic pain.
- Localized infection at the site of the block.
- Coagulopathies, patients on anticoagulants and antiplatelets, and significant liver or renal insufficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo Unviersity
Cairo, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
sherif mamdouh, MD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Randomization will be accomplished through the use of computer-generated random numbers and closed opaque envelopes. Another anesthesiologist who will not be involved in the other parts of the study will open the envelopes to enroll patients. and both patients and outcome assessors will be blinded to the assignment of groups.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
December 16, 2022
First Posted
March 30, 2023
Study Start
February 2, 2023
Primary Completion
October 12, 2023
Study Completion
November 1, 2023
Last Updated
August 30, 2023
Record last verified: 2023-08